Press releases
- BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
- BIO-TECHNE DECLARES DIVIDEND
- BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
- BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
- BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
- BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
- BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
- BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
- BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
- BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
More ▼
Key statistics
As of last trade Bio-Techne Corp (TE1:BER) traded at 70.00, -12.50% below its 52-week high of 80.00, set on Jul 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 70.00 |
---|---|
High | 70.00 |
Low | 70.00 |
Bid | 70.50 |
Offer | 72.00 |
Previous close | 68.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 157.19m |
Free float | 155.66m |
P/E (TTM) | -- |
Market cap | 11.88bn USD |
EPS (TTM) | -- |
Annual div (ADY) | 0.2988 EUR |
---|---|
Annual div yield (ADY) | 0.50% |
Div ex-date | Feb 09 2024 |
Div pay-date | Feb 26 2024 |
Next div ex-date | May 10 2024 |
Next div pay-date | May 24 2024 |
Data delayed at least 15 minutes, as of May 03 2024 07:08 BST.
More ▼